Reduced Risk Alternatives: Exploring Vaping and Heated Tobacco Products

Aug.03.2023
New options such as vaping and heated tobacco offer adult smokers reduced potential health risks compared to traditional cigarettes.

Although the best option is to quit smoking, those who are unable to do so have new options that can help reduce the damage caused to their health by cigarette consumption.

 

In recent years, tobacco companies have embarked on a transformation process, investing in innovation programs, technology, and scientific research to develop products that can offer adult smokers alternatives with reduced potential risk.

 

How they work and how they differ

Among the various options available on the market, vaping, also known as e-cigarettes, and heated or non-combustible tobacco stand out. And although surely all smokers have heard of these alternatives to cigarettes, do they really know about these products? Do they know what they consist of and how they work?

 

On one hand, vaping devices are based on a system that heats a liquid, which may or may not contain nicotine, to generate an inhalable vapor. This system eliminates tobacco combustion and reduces toxic levels by up to 95% compared to conventional cigarettes. The reason? It eliminates the smoke produced by burning traditional cigarettes. Therefore, these products have a potential reduced risk for smokers.

 

Another unique feature is that they eliminate bad odors. Most of the liquids used contain water, propylene glycol, glycerol, and flavors.

 

There are open, closed, and disposable systems. The main difference between the first two is that closed systems already have a pre-established pod, and users can choose from a range of flavors. As for open systems, the user has to manipulate the liquid, which is then filled into the tank, and it can also have different flavors. In the case of disposable devices, everything is integrated into a single unit: mouthpiece, battery, and liquid-heating atomizer.

 

Both vaping and heated tobacco are the result of years of research.

On the other hand, there are heated tobacco or non-combustible tobacco products that use the "heat not burn" technology. These are devices that heat specially designed tobacco units.

 

In this case, the tobacco is only heated to a temperature of up to 400°C without needing to reach high temperatures for burning (there is no combustion). This generates an aerosol that does not contain the solid particles found in cigarette smoke.

 

What do they have in common?

Although both alternatives to cigarettes eliminate tobacco combustion and are classified as options with reduced potential risk, they are not exactly the same products. However, in both cases, there is no combustion, which means there are no ashes or other residues, and they eliminate bad odors.

 

In the case of liquids, most of them contain water, propylene glycol, glycerol, and flavors, so they do not produce the unpleasant smell of traditional cigarettes, and the vapor aroma does not linger on hair or clothes. Similarly, heated tobacco products eliminate cigarette smoke, resulting in fewer persistent odors.

 

But most importantly, both options offer adult smokers alternatives to traditional tobacco consumption that can help, in many cases, to switch from the habit of smoking to the consumption of products with reduced potential risk.

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.
Apr.23 by 2FIRSTS.ai
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
mperial Brands’ HY26 results point to a more selective NGP transition. The company is using cash flow from traditional tobacco to fund targeted investments in modern oral nicotine, heated tobacco and reusable vaping systems. Its decision to exit the legacy myblu vaping business in the U.S., while expanding Zone nicotine pouches. In Europe, Imperial’s NGP growth is being driven by a multi-category portfolio including blu, Pulze and Zone/Skruf.
Special Report
May.12
Malaysian Court Rules Liquid Nicotine Exemption Irrational, Renewing Vape Regulation Debate
Malaysian Court Rules Liquid Nicotine Exemption Irrational, Renewing Vape Regulation Debate
Malaysia’s High Court ruled that the government’s earlier decision to remove liquid nicotine from the country’s Poisons List was “irrational,” reigniting debate over vape regulation, illicit trade, and youth protection.
Regulations
May.18
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas says newly released internal FDA records show agency scientific reviewers supported authorization for several flavored G2 products before senior leadership halted them. According to documents obtained through a Freedom of Information Act request, FDA’s Office of Science first recommended marketing authorization for all eight products in December 2025 and later supported six of them in February 2026. FDA ultimately authorized only the G2 device and one tobacco-flavored pod in March.
Apr.23 by 2FIRSTS.ai
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
U.S. Customs and Border Protection (CBP) announced that more than 18 million illegal e-cigarettes valued at over $175 million were seized during “Operation Red Mist,” a joint enforcement initiative involving the U.S. Coast Guard and the FDA. The operation primarily targeted maritime vape shipments originating from China and focused on combating illicit importation, transportation, and distribution activities.
Regulations
May.14
BAT France Confirms Full Compliance as France Implements Nicotine Pouch Ban on April 1from April 2026
BAT France Confirms Full Compliance as France Implements Nicotine Pouch Ban on April 1from April 2026
BAT France said that, under the decree of September 5, 2025 that entered into force on April 1, 2026, it has stopped commercialising its nicotine pouch products in France from that date.
Apr.03 by 2FIRSTS.ai